Acadia Healthcare (NASDAQ:ACHC) Cut to Outperform at Raymond James Financial

Raymond James Financial lowered shares of Acadia Healthcare (NASDAQ:ACHC) from a strong-buy rating to an outperform rating in a report issued on Monday morning, MarketBeat Ratings reports. Raymond James Financial currently has $39.00 target price on the stock.

A number of other equities analysts also recently commented on ACHC. Guggenheim lifted their target price on shares of Acadia Healthcare from $38.00 to $39.00 and gave the stock a “buy” rating in a research note on Thursday, July 30th. UBS Group raised their price target on shares of Acadia Healthcare from $31.00 to $39.00 and gave the stock a “buy” rating in a report on Thursday, July 9th. Barclays lifted their price target on shares of Acadia Healthcare from $25.00 to $32.00 and gave the company an “equal weight” rating in a research report on Thursday, July 30th. Leerink Partners upped their price objective on Acadia Healthcare from $30.00 to $33.00 and gave the company a “market perform” rating in a report on Wednesday, September 23rd. Finally, Weiss Ratings reissued a “sell (d)” rating on shares of Acadia Healthcare in a research note on Wednesday, September 9th. Eight research analysts have rated the stock with a Buy rating, five have assigned a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $30.69.

Acadia Healthcare Stock Down 1.9%

Shares of NASDAQ:ACHC opened at $27.50 on Monday. The company has a quick ratio of 1.57, a current ratio of 1.57 and a debt-to-equity ratio of 1.20. The business has a fifty day moving average of $29.32 and a two-hundred day moving average of $27.43. The stock has a market cap of $2.56 billion, a P/E ratio of -2.21, a PEG ratio of 9.03 and a beta of 0.62. Acadia Healthcare has a 52-week low of $11.43 and a 52-week high of $35.83.

Acadia Healthcare (NASDAQ:ACHC) last posted its quarterly earnings results on Tuesday, July 28th. The company reported $0.38 EPS for the quarter, topping the consensus estimate of $0.35 by $0.03. The business had revenue of $865.84 million for the quarter, compared to analyst estimates of $844.19 million. Acadia Healthcare had a positive return on equity of 6.19% and a negative net margin of 33.44%.The company’s quarterly revenue was down .4% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.83 EPS. Acadia Healthcare has set its FY 2026 guidance at 1.450-1.600 EPS. On average, research analysts expect that Acadia Healthcare will post 1.55 earnings per share for the current year.

Institutional Investors Weigh In On Acadia Healthcare

A number of institutional investors and hedge funds have recently made changes to their positions in ACHC. Clough Capital Partners L P acquired a new position in Acadia Healthcare during the 1st quarter worth about $5,359,000. Deutsche Bank AG acquired a new position in Acadia Healthcare in the 2nd quarter valued at about $49,746,000. Lisanti Capital Growth LLC purchased a new stake in Acadia Healthcare during the second quarter worth about $4,502,000. Royal Bank of Canada increased its stake in Acadia Healthcare by 7,896.1% during the first quarter. Royal Bank of Canada now owns 278,265 shares of the company’s stock worth $6,508,000 after purchasing an additional 274,785 shares during the period. Finally, Bank of America Corp DE lifted its position in shares of Acadia Healthcare by 64.7% during the first quarter. Bank of America Corp DE now owns 1,231,172 shares of the company’s stock worth $28,797,000 after purchasing an additional 483,649 shares in the last quarter.

About Acadia Healthcare

Acadia Healthcare Company, Inc is a provider of behavioral healthcare services. The company operates facilities that offer treatment for mental health conditions, substance use disorders and other behavioral health needs. Its services are designed for children, adolescents and adults and may include inpatient psychiatric care, residential treatment, outpatient programs and specialized care.

Acadia’s facilities provide a range of treatment programs, including psychiatric hospitals, addiction treatment centers, eating disorder programs and other specialty behavioral healthcare services.